RyboDyn
News,Biotech / MedTech,Singapore
Singapore’s AngelCentral backs US biotech firm Rybodyn
Singapore-based investor AngelCentral announced Wednesday its first successful BioTech syndicate by its members to invest in RyboDyn Inc., a US biotechnology company pioneering the development of immunotherapies targeting the dark genome.
July 23, 2026
Fujitsu and Paradigm test AI screening for Japan trials
November 20, 2026
MetaComp adds about $10M from Tether and Further
November 20, 2026
Fujitsu and Paradigm test AI screening for Japan trials
November 20, 2026
MetaComp adds about $10M from Tether and Further
November 20, 2026




